| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |